TEKLA CAPITAL MANAGEMENT LLC Mirati Therapeutics, Inc. Transaction History

TEKLA CAPITAL MANAGEMENT LLC portfolio value:

$8.54M
portfolio value

TEKLA CAPITAL MANAGEMENT LLC quarter portfolio value change:

+4.04%
quarter

Mirati Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +46.08% 38.60K shares 2.92M $69.84 122.39K
Q2 2022 share 0.00% 0 shares -1.26M $67.13 83.78K
Q1 2022 share 0.00% 0 shares -5.40M $82.22 83.78K
Q4 2021 share 0.00% 0 shares -2.53M $148.23 83.78K
Q3 2021 share 0.00% 0 shares 1.28M $176.91 83.78K
Q2 2021 share 0.00% 0 shares -818K $161.53 83.78K
Q1 2021 share 0.00% 0 shares -4.05M $171.3 83.78K
Q4 2020 share Increase +6.35% 5K shares 5.32M $219.64 83.78K
Q3 2020 share 0.00% 0 shares 4.08M $166.05 78.78K
Q2 2020 share 0.00% 0 shares 2.93M $114.17 78.78K
Q1 2020 share Increase +11.16% 7.91K shares -3.07M $76.87 78.78K
Q4 2019 share Decrease -11.06% -8.81K shares 2.92M $128.86 70.87K
Q3 2019 share Increase +486.36% 66.09K shares 4.80M $77.91 79.68K
Q2 2019 share 0.00% 0 shares 404K $103 13.59K
Q1 2019 share 0.00% 0 shares 420K $73.3 13.59K
Q4 2018 share 0.00% 0 shares -64K $42.42 13.59K
Q3 2018 share Increase 0.00% 13.59K shares 640K $47.1 13.59K